DE60035697D1 - Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren können - Google Patents
Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren könnenInfo
- Publication number
- DE60035697D1 DE60035697D1 DE60035697T DE60035697T DE60035697D1 DE 60035697 D1 DE60035697 D1 DE 60035697D1 DE 60035697 T DE60035697 T DE 60035697T DE 60035697 T DE60035697 T DE 60035697T DE 60035697 D1 DE60035697 D1 DE 60035697D1
- Authority
- DE
- Germany
- Prior art keywords
- tgf
- agents
- screening
- compounds
- dependent cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/385,918 US7358056B1 (en) | 1999-08-30 | 1999-08-30 | Methods for modulating signal transduction mediated by TGF-β and related proteins |
US385918 | 1999-08-30 | ||
PCT/US2000/023729 WO2001016604A1 (en) | 1999-08-30 | 2000-08-29 | Screening for agents modulating tgf-beta cell signaling |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60035697D1 true DE60035697D1 (de) | 2007-09-06 |
DE60035697T2 DE60035697T2 (de) | 2008-04-30 |
Family
ID=23523429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60035697T Expired - Fee Related DE60035697T2 (de) | 1999-08-30 | 2000-08-29 | Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren können |
Country Status (8)
Country | Link |
---|---|
US (2) | US7358056B1 (de) |
EP (2) | EP1918716A2 (de) |
JP (1) | JP2003508755A (de) |
AT (1) | ATE368227T1 (de) |
AU (1) | AU781152B2 (de) |
CA (1) | CA2383514A1 (de) |
DE (1) | DE60035697T2 (de) |
WO (1) | WO2001016604A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846746B2 (en) * | 2001-04-10 | 2010-12-07 | Children's Medical Center Corporation | Methods of analysis and labeling of protein-protein interactions |
US20030012818A1 (en) * | 2001-04-25 | 2003-01-16 | Eidgenossische Technische Hochschule Zurich And Universitat Zurich | Drug delivery matrices to enhance wound healing |
RU2322984C2 (ru) * | 2001-10-05 | 2008-04-27 | Комбинаторкс, Инкорпорейтед | Комбинации для лечения иммуновоспалительных расстройств |
GB0302315D0 (en) * | 2003-02-01 | 2003-03-05 | Univ East Anglia | Novel therapeutic target |
EP3059245B1 (de) * | 2004-07-23 | 2018-11-07 | Acceleron Pharma Inc. | Actrii-rezeptor antagonistische antikörper |
US20100183514A1 (en) * | 2007-05-29 | 2010-07-22 | President And Fellows Of Harvard College | Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof |
WO2011088163A1 (en) | 2010-01-14 | 2011-07-21 | President And Fellows Of Harvard College | Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination |
GB201013284D0 (en) * | 2010-08-06 | 2010-09-22 | Isogenica Ltd | Scaffold peptides |
PL2981822T4 (pl) | 2013-05-06 | 2021-07-12 | Scholar Rock, Inc. | Kompozycje i sposoby modulacji czynnika wzrostu |
CN103558395B (zh) * | 2013-10-28 | 2015-08-26 | 深圳市第二人民医院 | Smad3基因在检测上尿路上皮癌中的应用 |
KR101683544B1 (ko) * | 2014-12-19 | 2016-12-08 | 한양대학교 산학협력단 | 탈인산화 또는 인산화 효소 활성 검출용 조성물 및 검출 방법 |
US10961305B2 (en) | 2016-12-21 | 2021-03-30 | Mereo Biopharma 3 Limited | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta |
JP2022532216A (ja) * | 2019-05-15 | 2022-07-13 | シンセックス, インコーポレイテッド | タンパク質の選択的分解 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001619A (en) | 1995-10-04 | 1999-12-14 | Cold Spring Harbor Laboratory | Ubiquitin ligases, and uses related thereto |
US6011137A (en) * | 1996-04-03 | 2000-01-04 | University Of North Carolina At Chapel Hill | Identification and isolation of novel polypeptides having WW domains and methods of using same |
AU741242B2 (en) | 1997-05-20 | 2001-11-29 | Ludwig Institute For Cancer Research | Smad2 phosphorylation and interaction with Smad4 |
WO1999001765A1 (en) | 1997-07-01 | 1999-01-14 | Sloan Kettering Institute For Cancer Research | METHODS OF INHIBITING OR ENHANCING THE TGFβ-SMAD SIGNALING PATHWAY |
US6060262A (en) | 1997-07-16 | 2000-05-09 | Mitotix, Inc. | Regulation of I Kappa B (IκB) degradation and methods and reagents related thereto |
US5976849A (en) * | 1998-02-05 | 1999-11-02 | Zeneca Limited | Human E3 ubiquitin protein ligase |
JP2003502064A (ja) | 1999-06-11 | 2003-01-21 | ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク | BMPおよびTGFβシグナル伝達経路のアンタゴニスト |
-
1999
- 1999-08-30 US US09/385,918 patent/US7358056B1/en not_active Expired - Fee Related
-
2000
- 2000-08-29 AU AU70866/00A patent/AU781152B2/en not_active Ceased
- 2000-08-29 DE DE60035697T patent/DE60035697T2/de not_active Expired - Fee Related
- 2000-08-29 EP EP07010063A patent/EP1918716A2/de not_active Withdrawn
- 2000-08-29 EP EP00959571A patent/EP1212621B1/de not_active Expired - Lifetime
- 2000-08-29 AT AT00959571T patent/ATE368227T1/de not_active IP Right Cessation
- 2000-08-29 JP JP2001520108A patent/JP2003508755A/ja active Pending
- 2000-08-29 CA CA002383514A patent/CA2383514A1/en not_active Abandoned
- 2000-08-29 WO PCT/US2000/023729 patent/WO2001016604A1/en active IP Right Grant
-
2002
- 2002-12-02 US US10/307,956 patent/US20030119072A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7358056B1 (en) | 2008-04-15 |
EP1212621A1 (de) | 2002-06-12 |
ATE368227T1 (de) | 2007-08-15 |
EP1918716A2 (de) | 2008-05-07 |
JP2003508755A (ja) | 2003-03-04 |
DE60035697T2 (de) | 2008-04-30 |
WO2001016604A1 (en) | 2001-03-08 |
EP1212621B1 (de) | 2007-07-25 |
AU781152B2 (en) | 2005-05-12 |
AU7086600A (en) | 2001-03-26 |
US20030119072A1 (en) | 2003-06-26 |
CA2383514A1 (en) | 2001-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60035697D1 (de) | Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren können | |
DE59611411D1 (de) | Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz | |
PT934325E (pt) | Trisanidridos biciclicos de tetrafosfonato | |
ATE337021T1 (de) | Anordnungen, systeme und verfahren zur behandlung von biologischen flüssigkeiten mit licht | |
MX339420B (es) | Compuestos para la modulacion de la actividad de ppar gamma. | |
ATE353640T1 (de) | Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten | |
BR8802492A (pt) | Composicao esterilizante e de alto grau desinfetante,inodora | |
ATE413386T1 (de) | Ppar-gamma modulatoren | |
DE60029812D1 (de) | Diagnose von zellenproliferation sowie screeningverfahren für deren modulatore | |
AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
ATE255632T1 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
DE69940206D1 (de) | Verfahren zur behandlung von multiplem myelom und von myelom- induzierter knochenresorption mit antagonisten der integrin-/rezeptorbindung | |
ES2193919T3 (es) | Inhibidores de la enzima convertidora de endotelina. | |
DE69934595D1 (de) | Verwendung von verbindungen die alpha2-antiplasmin in vivo reduzieren zur herstellung einer zusammensetzung zur behandlung ischämischer schlaganfälle | |
DE69425820D1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
ATE259818T1 (de) | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen | |
DE69939723D1 (de) | Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie | |
DE3856329D1 (de) | Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie | |
DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
ES2063004T3 (es) | Antibioticos ab-006 y procedimiento para su produccion. | |
DE60034779D1 (de) | Insulinartiger-wachstumsfaktorbindungsprotein-4-protease | |
ATE288498T1 (de) | Methoden zur inhibierung von helicobacter pylori | |
ATE431399T1 (de) | Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit | |
DE69409961D1 (de) | Triarylethylenderivate zur therapeutischen verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |